- Shares of Evofem Biosciences, Inc. EVFM surged 16% after the clinical-stage biopharmaceutical company disclosed that the FDA had approved its birth control gel Phexxi.
- Shares of Benefitfocus, Inc. BNFT soared 15.1% after the provider of cloud-based benefits management platform reported $80 million investment by BuildGroup LLC.
- Shares of Sorrento Therapeutics, Inc. SRNE rose 3.9% after the clinical stage biopharma company received FDA IND clearance to initiate Phase I clinical trial of its CD38 antibody-drug conjugate (ADC) STI-6129.
- Shares of Cellectar Biosciences, Inc. CLRB gained 7.1% after it received FDA fast track designation for CLR 131 in Lymphoplasmacytic Lymphoma and Waldenstrom's Macroglobulinemia.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Benefitfocus, Inc. (BNFT) : Free Stock Analysis Report
Cellectar Biosciences, Inc. (CLRB) : Free Stock Analysis Report
Sorrento Therapeutics, Inc. (SRNE) : Free Stock Analysis Report
Neothetics, Inc. (EVFM) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research